Document is current
Any future updates will be listed below
-
Authors
Calabresi, Paolo http://orcid.org/0000-0003-0326-5509
Mechelli, Alessandro http://orcid.org/0000-0003-2493-6295
Natale, Giuseppina
Volpicelli-Daley, Laura
Di Lazzaro, Giulia
Ghiglieri, Veronica
- License Information
-
More Information
Article History
Received: 19 October 2022
Revised: 18 January 2023
Accepted: 9 February 2023
First Online: 1 March 2023
Competing interests
: PC received/receives research support, speaker honoraria, and support to attend national and international conferences (not related to the present study) from: Abbvie, Bial, Bayer Schering, Biogen-Dompè, Biogen-Idec, Eisai, Lilly, Lundbeck, Lusofarmaco, Merck-Serono, Novartis, Sanofi-Genzyme, Teva, UCB Pharma, Zambon. The other authors reported no funding from any institution, including personal relationships, interests, grants, employment, affiliations, patents, inventions, honoraria, consultancies, royalties, stock options/ownership, or expert testimony for the last 12 months biomedical financial interests or potential conflicts of interest.
